The data from New Zealand is all that is on the calendar.
These are unlikely to move the kiwi too much upon release.
The data from New Zealand is all that is on the calendar.
These are unlikely to move the kiwi too much upon release.
Most Popular
Sponsored
SpaceX accelerates employee vesting ahead of $2T IPO, potentially boosting share liquidity and investor returns.
CFTC probes hundreds of prediction market insider trades; potential conflicts of interest loom.
VOO fell 9% amid geopolitical fears, but recovered in <3 weeks. Long-term index investing wins!
RBC expects global central banks to largely hold rates despite oil-driven inflation risks, with policymakers prioritising growth concerns, while the RBA remains an outlier with further tightening likely.
RKLB's 577% return shines, but negative free cash flow (-53.8%) and high P/S (48.5x) raise valuation questions.
HIMS jumps 11% on FDA peptide review news; Bank of America raises PT to $25, reiterates neutral.
ROAD's 37.5% revenue growth & 49.6% EPS growth outshine TPC's flat sales & PD's weak billings.
Sponsored
Must Read